BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business
BioMarin Announces Record Fourth Quarter and Full Year 2022 Total Revenues Driven by Strong Global Demand for VOXZOGO® and Steady Growth of Enzyme Business - read this article along with other careers information, tips and advice on BioSpace
United States Marni Kottle Traci Mccarty Jean Jacques Bienaim European Commission Drug Administration
Source: biospace.com